Cargando…

Genome evolution of SARS-CoV-2 and its virological characteristics

Coronavirus disease of 2019 (COVID-19), which originated in China in 2019, shows mild cold and pneumonia symptoms that can occasionally worsen and result in deaths. SARS-CoV-2 was reported to be the causative agent of the disease and was identified as being similar to SARS-CoV, a causative agent of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, So, Miyazawa, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415347/
https://www.ncbi.nlm.nih.gov/pubmed/32834891
http://dx.doi.org/10.1186/s41232-020-00126-7
_version_ 1783569154725380096
author Nakagawa, So
Miyazawa, Takayuki
author_facet Nakagawa, So
Miyazawa, Takayuki
author_sort Nakagawa, So
collection PubMed
description Coronavirus disease of 2019 (COVID-19), which originated in China in 2019, shows mild cold and pneumonia symptoms that can occasionally worsen and result in deaths. SARS-CoV-2 was reported to be the causative agent of the disease and was identified as being similar to SARS-CoV, a causative agent of SARS in 2003. In this review, we described the phylogeny of SARS-CoV-2, covering various related studies, in particular, focusing on viruses obtained from horseshoe bats and pangolins that belong to Sarbecovirus, a subgenus of Betacoronavirus. We also describe the virological characteristics of SARS-CoV-2 and compare them with other coronaviruses. More than 30,000 genome sequences of SARS-CoV-2 are available in the GISAID database as of May 28, 2020. Using the genome sequence data of closely related viruses, the genomic characteristics and evolution of SARS-CoV-2 were extensively studied. However, given the global prevalence of COVID-19 and the large number of associated deaths, further computational and experimental virological analyses are required to fully characterize SARS-CoV-2.
format Online
Article
Text
id pubmed-7415347
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74153472020-08-10 Genome evolution of SARS-CoV-2 and its virological characteristics Nakagawa, So Miyazawa, Takayuki Inflamm Regen Review Coronavirus disease of 2019 (COVID-19), which originated in China in 2019, shows mild cold and pneumonia symptoms that can occasionally worsen and result in deaths. SARS-CoV-2 was reported to be the causative agent of the disease and was identified as being similar to SARS-CoV, a causative agent of SARS in 2003. In this review, we described the phylogeny of SARS-CoV-2, covering various related studies, in particular, focusing on viruses obtained from horseshoe bats and pangolins that belong to Sarbecovirus, a subgenus of Betacoronavirus. We also describe the virological characteristics of SARS-CoV-2 and compare them with other coronaviruses. More than 30,000 genome sequences of SARS-CoV-2 are available in the GISAID database as of May 28, 2020. Using the genome sequence data of closely related viruses, the genomic characteristics and evolution of SARS-CoV-2 were extensively studied. However, given the global prevalence of COVID-19 and the large number of associated deaths, further computational and experimental virological analyses are required to fully characterize SARS-CoV-2. BioMed Central 2020-08-10 /pmc/articles/PMC7415347/ /pubmed/32834891 http://dx.doi.org/10.1186/s41232-020-00126-7 Text en © The Author(s) 2020, corrected publication 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Nakagawa, So
Miyazawa, Takayuki
Genome evolution of SARS-CoV-2 and its virological characteristics
title Genome evolution of SARS-CoV-2 and its virological characteristics
title_full Genome evolution of SARS-CoV-2 and its virological characteristics
title_fullStr Genome evolution of SARS-CoV-2 and its virological characteristics
title_full_unstemmed Genome evolution of SARS-CoV-2 and its virological characteristics
title_short Genome evolution of SARS-CoV-2 and its virological characteristics
title_sort genome evolution of sars-cov-2 and its virological characteristics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415347/
https://www.ncbi.nlm.nih.gov/pubmed/32834891
http://dx.doi.org/10.1186/s41232-020-00126-7
work_keys_str_mv AT nakagawaso genomeevolutionofsarscov2anditsvirologicalcharacteristics
AT miyazawatakayuki genomeevolutionofsarscov2anditsvirologicalcharacteristics